Stocks
Haemonetics Corporation (HAE) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 9.72% | 9.43% | 9.43% | 5.06% | 23.1% | ||||
| Changes by years, y/y, % | +5pp | 0pp | 0pp | -9pp | -16.3% | ||||
Haemonetics Corporation. CAPEX/Revenue, %
Haemonetics Corporation. CAPEX/Revenue, changes, pp
Haemonetics Corporation (HAE) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
| CAPEX/Revenue, % | 3.10% | 7.75% | 6.63% | 73.9% | 2.82% | 23.1% | ||
| Changes by years, y/y, % | -14pp | -4pp | +1pp | +70pp | -1pp | |||
| Changes by quarters, q/q, % | -1pp | +5pp | -1pp | +67pp | -71pp | |||
